what is tirzepatide glp 1 FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Expert GLP-1 Tirzepatide Weight Loss

While both companies that have a monopoly on these drugs (Novo Nordisk and Eli Lilly) have enjoyed an incredible run-up from 2020 to 2024, both are now in a drawdown

As part of our Collaborative Care, you get to chose which program and medication/s to use, if you are just starting up, and also if you are already on a maintenance dose

Huberman has also publicly discussed the difference between medications developed through regulated research and products obtained through questionable gray-market sources

Discussing this upfront sets realistic expectations and demonstrates your commitment to sustained treatment

How tirzepatide differs Tirzepatide takes the concept further by activating both GLP-1 and GIP receptors simultaneously

"Well, how do we get them in our body